SCHEMBL117780

SCHEMBL117780

OC[C@H]1O[C@H](O)[C@@H](OCc2ccccc2)[C@@H](O)[C@@H]1O

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.56
PDE4D Q08499 1/20 0.45
SLC5A2 P31639 3/20 0.45
HRAS P01112 2/20 0.44
LGALS8 O00214 1/20 0.44
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
SLC29A1 Q99808 1/20 0.42
PDPK1 O15530 1/20 0.42
MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17080335 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8517368 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL9001315 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL9849302 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL7638059 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL5265599 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL5674181 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL4279552 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8517068 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8
SCHEMBL8418092 1.00 SLC6A2 (0.56) SLC6A2PDE4DSLC5A2HRASLGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11147219-B2 Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same INNOVATION HAMMER, LLC (US) 2021-10-19 US disclosed
EP-3783093-A2 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES Innovation Hammer LLC (US) 2021-02-24 EP disclosed
EP-2782990-B1 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES INNOVATION HAMMER LLC (US) 2020-10-07 EP disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-20200113143-A1 Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same INNOVATION HAMMER LLC (US) 2020-04-16 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
EP-3350192-B1 MULTI-FUNCTIONALIZED POLYSACCHARIDE COMPOUNDS AND USE THEREOF FOR TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR NANOMEDSYN (FR) 2019-08-07 EP disclosed
US-20180325045-A1 Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same INNOVATION HAMMER LLC (US) 2018-11-15 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
US-10010029-B2 Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same INNOVATION HAMMER, LLC (US) 2018-07-03 US disclosed
US-8637578-B2 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins ISIS INNOVATION LIMITED (GB) 2014-01-28 US disclosed
US-20120100097-A1 CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES AHLSTROM CORPORATION (FI) 2012-04-26 US disclosed
EP-2424487-A2 CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES Ahlstrom Corporation (FI) 2012-03-07 EP disclosed
WO-2010125239-A2 CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES AHLSTROM CORPORATION (FI) 2010-11-04 WO disclosed
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins ISIS INNOVATION LIMITED (GB) 2007-09-13 US disclosed
EP-1644390-A2 REAGENTS AND METHODS FOR THE FORMATION OF DISULFIDE BONDS AND THE GLYCOSYLATION OF PROTEINS ISIS INNOVATION LIMITED (GB) 2006-04-12 EP disclosed
WO-2005000862-A2 REAGENTS AND METHODS FOR THE FORMATION OF DISULFIDE BONDS AND THE GLYCOSYLATION OF PROTEINS ISIS INNOVATION LIMITED (GB) 2005-01-06 WO disclosed
US-5633261-A ANTITUMOR AGENTS TORONTO RESEARCH CHEMICALS, INC. (CA) 1997-05-27 US disclosed
US-5621106-A REACTING WITH DIALKYLTIN OXIDE; ACYLATION; ALKYLATION TORONTO RESEARCH CHEMICALS, INC. (CA) 1997-04-15 US disclosed
US-5466809-A From aminomannose, antitumor agents, castanospermine TORONTO RESEARCH CHEMICALS, INC. (CA) 1995-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A SLC6A2 4054/4885PDE4D 4208/4885SLC5A2 3761/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 SLC6A2 3674/4885PDE4D 4502/4885SLC5A2 3532/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 SLC6A2 3892/4885PDE4D 4400/4885SLC5A2 3458/4885
US-20070213506-A1 Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins SCLY, PTMS, TST SLC6A2 2995/4885PDE4D 4838/4885SLC5A2 840/4885
US-20120100097-A1 CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES ALG1, CHIT1, MAN2A1 SLC6A2 4613/4885PDE4D 1063/4885SLC5A2 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.